Wenjie Zheng

8PUBLICATIONS
6CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

|Apr 21, 2026
A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

|Dec 22, 2025
Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance.

Jie Gao, Nan Bai, Mingyu Liu

|Apr 14, 2025
Endothelial Cell-Derived Exosomes Inhibit Osteoblast Apoptosis and Steroid-Induced Necrosis of Femoral Head Progression by Activating the PI3K/Akt/Bcl-2 Pathway.

Jie Sun, Chen Yao, Wanxin Luo

|Jul 15, 2024
Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization.

Saiyan Bian, Wenkai Ni, Linlin Zhou

|Feb 12, 2024
Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma.

Huiyuan Qiu, Bo Jiang, Yinqi Chen

Pageof 2

Frequent Collaborators

4 joint publications

Hui Zhao

2 joint publications

Yifu Xiao

1 joint publications

Dong Liu

1 joint publications

Jie Sun